Srinagar, Dec 11 (Reporter) Sher-i-Kashmir Institute of Medical Sciences (SKIMS) has partnered with Novo Nordisk India Pvt. Ltd. to advance clinical research in India. This landmark Memorandum of Understanding (MoU), valid for three years, establishes a robust framework for innovation in healthcare and clinical trials. This partnership marks a significant milestone for both organisations as they join forces to innovate and transform the clinical research landscape, ultimately aiming to improve patient outcomes. Director SKIMS Mohammed Ashraf Ganie said this collaboration represents a significant step towards elevating clinical research standards in the region. “By collaborating with Novo Nordisk India Pvt. Ltd., SKIMS aims to contribute to groundbreaking advancements in medical science while ensuring that the people of Jammu and Kashmir have access to world-class healthcare. Together, we are committed to transforming patient care and addressing the unmet medical needs of our community,” he said. Commenting on the MoU signing, Vikrant Shrotriya, Managing Director and Corporate Vice President, Novo Nordisk India Pvt. Ltd., said this partnership underscores their unwavering commitment to redefining the future of clinical research in India. “By uniting our global expertise in innovative therapeutics with SKIMS’ exceptional medical infrastructure, we aim to create transformative healthcare solutions. This partnership aspires to bridge gaps in access to advanced medicines, delivering life-changing outcomes for patients in underserved communities and beyond,” he said. A first of its kind, this MoU for clinical trials with a medical institute in the region, is valid for three years and opens doors to long-term collaboration, a statement issued after the MoU read. “ The partnership aims to explore groundbreaking solutions in cardiology, obesity, nephrology and rare diseases by leveraging Novo Nordisk’s expertise in developing advanced therapeutics and SKIMS’ robust medical infrastructure,” t added. As part of the MoU, Novo Nordisk will contribute to building research capacity by providing resources, clinical research, relevant training and project-related equipment. This initiative also aims to enhance the capabilities of the clinical research team at SKIMS, ensuring the outreach of life-saving medicines to a larger patient population. SKIMS will play a pivotal role in expediting the approval process for clinical trials, facilitating patient participation, care and ensuring their safety and convenience...////...